Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A complex neurodevelopmental disorder caused by variation in DHX30. Individuals with variants in DHX30 have been found to have variable presentations including intellectual disability, delayed or absent speech development, delayed motor development, hypotonia, feeding difficulties, and ataxic gait or the inability to walk. Other phenotypic features commonly reported include sleep disorders, autistic features, seizures, and joint hypermobility
Features include always present findings: Low muscle tone (hypotonia), Intellectual disability, Motor delay, and Delayed speech and language development; and very common findings: Absent speech. 56 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 15 | Inability to walk, Dystonia, Seizure |
DHX30 encodes DExH-box helicase 30 (1,194 aa). RNA-dependent helicase. Plays an important role in the assembly of the mitochondrial large ribosomal subunit. Required for optimal function of the zinc-finger antiviral protein ZC3HAV1. Highest expression in Testis (97.4 TPM) and Brain Cerebellum (64.9 TPM).
Neurodevelopmental disorder with severe motor impairment and absent language is caused by mutations in the DHX30 gene on chromosome 3.
DHX30 is classified as a druggable target with score 0.0.
Genetic testing for DHX30 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for neurodevelopmental disorder with severe motor impairment and absent language has been reported in the published literature.
Phenotype severity distribution: 4 always present features, 1 very common feature, 9 common features.
No clinical trials have been registered for neurodevelopmental disorder with severe motor impairment and absent language.
10 publications have been identified in PubMed for neurodevelopmental disorder with severe motor impairment and absent language. Research spans Case Report / Case Series (40%), Basic Science / Preclinical (30%), and Other (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 4 | 40% |
Data assembled from 7 of 12 sources · Last updated Sep 20, 2026, 4:11 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Head and neck
6 |
Microcephaly, High palate, Small face |
Arms and legs | 3 | Prominent fingertip pads, Tapered finger, Stereotypical hand wringing |
Muscles | 3 | Low muscle tone (hypotonia), Shrinkage of the cerebellum (cerebellar atrophy), Brain shrinkage (cerebral atrophy) |
Bones and joints | 2 | Joint hypermobility, Sideways curvature of the spine (scoliosis) |
Eyes | 1 | Strabismus |
Digestive system | 1 | Feeding difficulties |
Skin | 1 | Thin skin |
Laboratory research |
3 |
30% |
Other research | 1 | 10% |
Testing and diagnosis research | 1 | 10% |
New treatment approaches | 1 | 10% |
Politano D (2026). [PMID: 42146894](https://pubmed.ncbi.nlm.nih.gov/42146894/). *Neurol Genet*. [Case Report / Case Series]
Linares M (2026). [PMID: 41915758](https://pubmed.ncbi.nlm.nih.gov/41915758/). *Arch Argent Pediatr*. [Other]
Zhao L (2026). [PMID: 41960028](https://pubmed.ncbi.nlm.nih.gov/41960028/). *Front Pediatr*. [Case Report / Case Series]
Slušná D (2025). [PMID: 40919408](https://pubmed.ncbi.nlm.nih.gov/40919408/). *Front Hum Neurosci*. [Diagnostic / Biomarker]
Linares M (2025). [PMID: 40591572](https://pubmed.ncbi.nlm.nih.gov/40591572/). *Arch Argent Pediatr*. [Case Report / Case Series]
Lee KH (2025). [PMID: 38826421](https://pubmed.ncbi.nlm.nih.gov/38826421/). *bioRxiv*. [Basic Science / Preclinical]
San José Cáceres A (2024). [PMID: 39563223](https://pubmed.ncbi.nlm.nih.gov/39563223/). *J Neurodev Disord*. [Basic Science / Preclinical]
Gunasekaran PK (2024). [PMID: 39150459](https://pubmed.ncbi.nlm.nih.gov/39150459/). *Ann Indian Acad Neurol*. [Case Report / Case Series]
Le C (2024). [PMID: 39502664](https://pubmed.ncbi.nlm.nih.gov/39502664/). *medRxiv*. [Basic Science / Preclinical]
Zanetti A (2024). [PMID: 39572588](https://pubmed.ncbi.nlm.nih.gov/39572588/). *Nat Commun*. [Gene Therapy / Novel Therapeutics]